Drug Shortage Report for TAMSULOSIN CR

Last updated on 2024-09-20 History
Report ID 215019
Drug Identification Number 02413612
Brand name TAMSULOSIN CR
Common or Proper name TAMSULOSIN CR
Company Name PRO DOC LIMITEE
Market Status MARKETED
Active Ingredient(s) TAMSULOSIN HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30, 500
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2024-08-31
Actual start date 2024-08-31
Estimated end date 2024-12-03
Actual end date 2024-09-19
Shortage status Resolved
Updated date 2024-09-20
Company comments in allocation
Health Canada comments
Tier 3 Status Yes
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2024-09-20 English Compare
v14 2024-09-19 French Compare
v13 2024-09-19 English Compare
v12 2024-09-05 French Compare
v11 2024-09-05 English Compare
v10 2024-09-05 French Compare
v9 2024-09-05 English Compare
v8 2024-09-03 French Compare
v7 2024-09-03 English Compare
v6 2024-09-01 English Compare
v5 2024-08-16 French Compare
v4 2024-08-16 English Compare
v3 2024-01-30 English Compare
v2 2024-01-05 French Compare
v1 2024-01-05 English Compare

Showing 1 to 15 of 15